.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Army
McKinsey
Covington
Accenture
Mallinckrodt
Healthtrust
Farmers Insurance
Fish and Richardson
Cipla

Generated: December 18, 2017

DrugPatentWatch Database Preview

Lannett Company Profile

« Back to Dashboard

What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?

LANNETT has one hundred and fifteen approved drugs.



Summary for Lannett

US Patents:0
Tradenames:84
Ingredients:82
NDAs:115
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
LannettQUINALANquinidine gluconateTABLET, EXTENDED RELEASE;ORAL088081-001Feb 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
LannettTERBUTALINE SULFATEterbutaline sulfateTABLET;ORAL077152-002Mar 25, 2005RXNoYes► Subscribe► Subscribe► Subscribe
LannettLANTRISULtrisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)SUSPENSION;ORAL080123-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings IncAMANTADINE HYDROCHLORIDEamantadine hydrochlorideCAPSULE;ORAL209221-001Jun 15, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings IncHYDROCODONE BITARTRATE AND ACETAMINOPHENacetaminophen; hydrocodone bitartrateTABLET;ORAL207172-001Jun 22, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
LannettPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideCAPSULE;ORAL083693-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
LannettPREDNISOLONEprednisoloneTABLET;ORAL080531-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings IncCODEINE SULFATEcodeine sulfateTABLET;ORAL203046-002Jun 13, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
LannettRIFAMPINrifampinCAPSULE;ORAL065390-001Mar 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
LannettDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEatropine sulfate; diphenoxylate hydrochlorideTABLET;ORAL085372-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chubb
Johnson and Johnson
Express Scripts
McKesson
Teva
Argus Health
Julphar
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot